102 related articles for article (PubMed ID: 10449612)
1. Analysis of the RAD54 gene on chromosome 1p as a potential tumor-suppressor gene in parathyroid adenomas.
Carling T; Imanishi Y; Gaz RD; Arnold A
Int J Cancer; 1999 Sep; 83(1):80-2. PubMed ID: 10449612
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid tumor suppressor on 1p: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate.
Tahara H; Smith AP; Gaz RD; Zariwala M; Xiong Y; Arnold A
J Bone Miner Res; 1997 Sep; 12(9):1330-4. PubMed ID: 9286748
[TBL] [Abstract][Full Text] [Related]
3. Frequent loss of chromosome arm 1p DNA in parathyroid adenomas.
Cryns VL; Yi SM; Tahara H; Gaz RD; Arnold A
Genes Chromosomes Cancer; 1995 May; 13(1):9-17. PubMed ID: 7541648
[TBL] [Abstract][Full Text] [Related]
4. Putative parathyroid tumor suppressor on 1p: independent molecular mechanisms of tumorigenesis from 11q allelic loss.
Imanishi Y; Tahara H
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S165-7. PubMed ID: 11576946
[TBL] [Abstract][Full Text] [Related]
5. RAD51 as a candidate parathyroid tumour suppressor gene on chromosome 15q: absence of somatic mutations.
Carling T; Imanishi Y; Gaz RD; Arnold A
Clin Endocrinol (Oxf); 1999 Oct; 51(4):403-7. PubMed ID: 10583305
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the vitamin D receptor does not support its candidacy as a tumor suppressor gene in parathyroid adenomas.
Samander EH; Arnold A
J Clin Endocrinol Metab; 2006 Dec; 91(12):5019-21. PubMed ID: 17003089
[TBL] [Abstract][Full Text] [Related]
7. Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas.
Välimäki S; Forsberg L; Farnebo LO; Larsson C
Int J Oncol; 2002 Oct; 21(4):727-35. PubMed ID: 12239610
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of heterozygosity at 1p36.3 and p73 abnormality in parathyroid adenomas.
Shan L; Yang Q; Nakamura Y; Nakamura M; Miyauchi A; Tsujimoto M; Nakatani Y; Wakasa K; Mori I; Kakudo K
Mod Pathol; 2001 Apr; 14(4):273-8. PubMed ID: 11301342
[TBL] [Abstract][Full Text] [Related]
9. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas.
Tahara H; Smith AP; Gas RD; Cryns VL; Arnold A
Cancer Res; 1996 Feb; 56(3):599-605. PubMed ID: 8564978
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism.
Carling T; Correa P; Hessman O; Hedberg J; Skogseid B; Lindberg D; Rastad J; Westin G; Akerström G
J Clin Endocrinol Metab; 1998 Aug; 83(8):2960-3. PubMed ID: 9709976
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathogenesis of primary hyperparathyroidism.
Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
[TBL] [Abstract][Full Text] [Related]
12. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas.
Palanisamy N; Imanishi Y; Rao PH; Tahara H; Chaganti RS; Arnold A
J Clin Endocrinol Metab; 1998 May; 83(5):1766-70. PubMed ID: 9589690
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability and loss of heterozygosity in primary and secondary proliferative lesions of the parathyroid gland.
Koshiishi N; Chong JM; Fukasawa T; Ikeno R; Tanaka A; Kanazawa K; Ogura M; Ebuchi M; Takizawa T; Funata N; Fukayama M
Lab Invest; 1999 Sep; 79(9):1051-8. PubMed ID: 10496523
[TBL] [Abstract][Full Text] [Related]
14. A possible tumor suppressor gene for parathyroid adenomas.
Iwasaki H
Int Surg; 1996; 81(1):71-6. PubMed ID: 8803711
[TBL] [Abstract][Full Text] [Related]
15. Genetic and clinical characterization of sporadic cystic parathyroid tumours.
Villablanca A; Farnebo F; Teh BT; Farnebo LO; Höög A; Larsson C
Clin Endocrinol (Oxf); 2002 Feb; 56(2):261-9. PubMed ID: 11874419
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-beta and menin pathways, in parathyroid adenomas and enteropancreatic endocrine tumors.
Shattuck TM; Costa J; Bernstein M; Jensen RT; Chung DC; Arnold A
J Clin Endocrinol Metab; 2002 Aug; 87(8):3911-4. PubMed ID: 12161532
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability in sporadic parathyroid adenoma.
Sarquis M; Friedman E; Boson WL; Gomez RS; Dias AF; De Marco L
J Clin Endocrinol Metab; 2000 Jan; 85(1):250-2. PubMed ID: 10634395
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the human homologue of RAD54: a gene located on chromosome 1p32 at a region of high loss of heterozygosity in breast tumors.
Rasio D; Murakumo Y; Robbins D; Roth T; Silver A; Negrini M; Schmidt C; Burczak J; Fishel R; Croce CM
Cancer Res; 1997 Jun; 57(12):2378-83. PubMed ID: 9192813
[TBL] [Abstract][Full Text] [Related]
19. MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism.
Cetani F; Pardi E; Vignali E; Borsari S; Picone A; Cianferotti L; Ambrogini E; Miccoli P; Pinchera A; Marcocci C
J Endocrinol Invest; 2002 Jun; 25(6):508-12. PubMed ID: 12109621
[TBL] [Abstract][Full Text] [Related]
20. Identification of somatic mutations in parathyroid tumors using whole-exome sequencing.
Cromer MK; Starker LF; Choi M; Udelsman R; Nelson-Williams C; Lifton RP; Carling T
J Clin Endocrinol Metab; 2012 Sep; 97(9):E1774-81. PubMed ID: 22740705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
